Search results
Results from the WOW.Com Content Network
Primidone, sold under various brand names (including Mysoline), is a barbiturate medication that is used to treat partial and generalized seizures [7] and essential tremors. [8] It is taken by mouth .
Barbiturates slow down the central nervous system and cause tranquilizing or antiseizure effects. Phenytoin and primidone are effective antiepileptics drugs, although phenytoin can cause liver failure or have other harmful long-term effects in patients with PME. Sodium valproate is an alternative therapy for myoclonus and can be used either ...
Other types of tremor may also occur, including postural tremor of the outstretched arms, intention tremor of the arms, and rest tremor in the arms. [16] In one study, men had more severe postural hand tremor when compared to women. [14] Some people may have unsteadiness and problems with gait and balance. [17]
Doing the same motion repeatedly can cause muscles, ligaments, and tendons to become swollen and inflamed, which causes the ache. In addition to aches, you may notice a lack of strength and ...
This causes tremors, slowness, stiffness, and walking and balance problems, among other issues, for the 1 million people affected by the disease in the U.S. and 6 million affected worldwide.
Tremor (usually fine shaking; tremor of the outstretched fingers). In a small study of newly diagnosed hyperthyroid patients, tremor was observed in 76% of them. [7] Some studies lay the cause for hyperthyroid tremor with a heightened beta-adrenergic state, others suggest an increased metabolism of dopamine. [8] [9]
A migraine attack can be a debilitating condition. But a headache is just one part. There are other subtle warning symptoms to watch out for, neurologists say.
Other dopamine antagonists and antiemetics can cause tardive dyskinesia, such as metoclopramide and promethazine, used to treat gastrointestinal disorders. Atypical antipsychotics are considered lower-risk for causing TD than their typical counterparts, with incidence rates of 13.1% and 32.4% respectively in short-term trials primarily ...